Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...

While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Opens in a new tab or window Until about 20 years ago, systemic treatment ... and biologic therapies remained in various stages of development. The most recent AAD/National Psoriasis Foundation ...

Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.

This analysis involving patients in the U.K. and Ireland provides reassurance on the effectiveness of two adalimumab biosimilars for the treatment of psoriasis ... since the biologic's patent ...

However, these tools sometimes aren’t enough, and you may need help from a dermatologist ... warrant the use of a biologic, then you’ll most likely need lifelong treatment.

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...

The label expansion could help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar ...

Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well as Crohn's disease and ulcerative colitis in adult patients.